INHIBITORS OF MENIN-MLL INTERACTION

To provide novel drugs for inhibiting the menin-MLL interaction.SOLUTION: The present invention provides a compound of Formula I or a pharmaceutically acceptable salt thereof.SELECTED DRAWING: None 【課題】メニン－ＭＬＬ相互作用を阻害する新規薬剤を提供する。【解決手段】式Ｉの化合物又はその医薬的に許容し得るその塩を提供する。TIFF2024045176000454.tif72170【選択図】なし...

Full description

Saved in:
Bibliographic Details
Main Authors DAVID A CLAREMON, SURESH B SINGH, SALVACION CACATIAN, ANDREW MARCUS, ANGEL MORALES-RAMOS, STEPHEN D LOTESTA, ZHENG YAJUN, ZHUANG LINGHANG, JIA LANQI, TRAVIS L HOUSTON, YI FAN, SHANKAR VENKATRAMAN, YUAN JING, DONG CHENGGUO, STEPHAN D PARENT, LAWRENCE WAYNE DILLARD
Format Patent
LanguageEnglish
Japanese
Published 02.04.2024
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:To provide novel drugs for inhibiting the menin-MLL interaction.SOLUTION: The present invention provides a compound of Formula I or a pharmaceutically acceptable salt thereof.SELECTED DRAWING: None 【課題】メニン－ＭＬＬ相互作用を阻害する新規薬剤を提供する。【解決手段】式Ｉの化合物又はその医薬的に許容し得るその塩を提供する。TIFF2024045176000454.tif72170【選択図】なし
Bibliography:Application Number: JP20240000278